Division of Nephrology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
PLoS One. 2012;7(1):e27687. doi: 10.1371/journal.pone.0027687. Epub 2012 Jan 20.
Preoperative proteinuria is associated with post-operative acute kidney injury (AKI), but whether it is also associated with increased long-term mortality and end-stage renal disease (ESRD) is unknown.
We studied 925 consecutive patients undergoing CABG. Demographic and clinical data were collected prospectively, and patients were followed for a median of 4.71 years after surgery. Proteinuria, according to dipstick tests, was defined as mild (trace to 1+) or heavy (2+ to 4+) according to the results of the dipstick test. A total of 276 (29.8%) patients had mild proteinuria before surgery and 119 (12.9%) patients had heavy proteinuria. During the follow-up, the Cox proportional hazards model demonstrated that heavy proteinuria (hazard ratio [HR], 27.17) was an independent predictor of long-term ESRD. There was a progressive increased risk for mild proteinuria ([HR], 1.88) and heavy proteinuria ([HR], 2.28) to predict all-cause mortality compared to no proteinuria. Mild ([HR], 2.57) and heavy proteinuria ([HR], 2.70) exhibited a stepwise increased ratio compared to patients without proteinuria for long-term composite catastrophic outcomes (mortality and ESRD), which were independent of the baseline GFR and postoperative acute kidney injury (AKI).
Our study demonstrated that proteinuria is a powerful independent risk factor of long-term all-cause mortality and ESRD after CABG in addition to preoperative GFR and postoperative AKI. Our study demonstrated that proteinuria should be integrated into clinical risk prediction models for long-term outcomes after CABG. These results provide a high priority for future renal protective strategies and methods for post-operative CABG patients.
术前蛋白尿与术后急性肾损伤(AKI)相关,但它是否也与长期死亡率和终末期肾病(ESRD)增加相关尚不清楚。
我们研究了 925 例连续接受 CABG 的患者。前瞻性收集人口统计学和临床数据,术后中位随访时间为 4.71 年。根据尿试纸检测结果,将蛋白尿定义为轻度(微量至 1+)或重度(2+至 4+)。共有 276 例(29.8%)患者术前有轻度蛋白尿,119 例(12.9%)患者有重度蛋白尿。在随访期间,Cox 比例风险模型显示重度蛋白尿(危险比[HR],27.17)是长期 ESRD 的独立预测因子。与无蛋白尿相比,轻度蛋白尿(HR,1.88)和重度蛋白尿(HR,2.28)预测全因死亡率的风险逐渐增加。与无蛋白尿患者相比,轻度蛋白尿(HR,2.57)和重度蛋白尿(HR,2.70)预测长期复合灾难性结局(死亡率和 ESRD)的比值呈递增趋势,且独立于基线肾小球滤过率和术后 AKI。
本研究表明,除术前 GFR 和术后 AKI 外,蛋白尿是 CABG 后长期全因死亡率和 ESRD 的有力独立危险因素。本研究表明,蛋白尿应纳入 CABG 后长期结局的临床风险预测模型。这些结果为术后 CABG 患者的肾脏保护策略和方法提供了高度优先考虑的依据。